Paroxetine 25mg ER Tablets

Paroxetine 25mg ER tablet is an extended-release SSRI antidepressant used for major depression, panic disorder, social anxiety disorder and selected premenstrual dysphoric-disorder regimens. Its release design differs from immediate-release tablets.
Take the extended-release tablet at a consistent morning time, with or without food. Swallow intact without crushing or chewing; a switch from immediate-release treatment needs a planned conversion.
Inhibition of the serotonin transporter increases serotonin availability at synapses involved in mood and anxiety regulation.
Nausea, sweating, sleep disturbance, dry mouth, constipation and sexual dysfunction may occur.
Tell your doctor about bipolar disorder, low sodium, glaucoma and other serotonergic medicines. Do not combine paroxetine with MAO inhibitors. It can reduce tamoxifen activation. New suicidal thoughts or major behavioural changes need urgent assessment.
Can reduce persistent depressive or anxiety symptoms and associated functional impairment over continued treatment.
Mood and anxiety responses usually develop over several weeks rather than after one tablet.
Yes. Paroxetine can cause discontinuation symptoms after interruption or rapid reduction.
Discontinuation symptoms do not by themselves mean craving-based addiction, but gradual tapering is still important.
Reduced desire, delayed orgasm or other sexual effects can occur and should be discussed.
Paroxetine can reduce tamoxifen activation; the cancer team should select an appropriate alternative if needed.
Seek urgent care for possible serotonin syndrome, especially after adding another serotonergic medicine.
Yes. Discuss reproductive risks and alternatives without abruptly stopping treatment.
No. Crushing alters release and is unsuitable for controlled-release tablets.
SSRI: selective serotonin reuptake inhibitor. Discontinuation symptoms: symptoms after rapid dose reduction. Hyponatraemia: an abnormally low blood-sodium concentration.; AR: Paroxetine 25mg أقراص ممتدة التحرر; FR: Paroxetine 25mg comprimés à libération prolongée; PT: Paroxetine 25mg comprimidos de libertação prolongada; ES: Paroxetine 25mg comprimidos de liberación prolongada; RU: Paroxetine 25mg таблетки пролонгированного действия; ID: Paroxetine 25mg tablet lepas lambat; VI: Paroxetine 25mg viên nén giải phóng kéo dài; MS: Paroxetine 25mg tablet pelepasan berpanjangan; TL: Paroxetine 25mg tabletang may pinahabang paglabas; ZH-SG: Paroxetine 25mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Paroxetine 25mg ER Tablets under Mental Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Paroxetine 25mg ER Tablets